Gedatolisib

未知生产厂商

Gedatolisib has been used in trials studying the basic science and treatment of Neoplasm, Ovary Cancer, Breast Cancer, Advanced Cancer, and Endometrial Cancer, among others.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Gedatolisib has been used in trials studying the basic science and treatment of Neoplasm, Ovary Cancer, Breast Cancer, Advanced Cancer, and Endometrial Cancer, among others.

技术标识符

化学式: C₃₂H₄₁N₉O₄
CAS 编号: 1197160-78-3
UNII ID: 96265TNH2R

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA (GEDATOLISIB) AND ITS COMBINATIONS FOR USE IN THE TREATMENT OF BREAST CANCER
EP 4376848 B1申请人: CELCUITY INC优先权: 2021
EP
US
WO
6 件公开
TREATMENT REGIMENS FOR GEDATOLISIB IN HORMONALLY-DRIVEN DISORDERS
US 20260053814 A1申请人: CELCUITY INC优先权: 2024
US
WO
2 件公开
Preparation method of Gedatolisib and intermediate
CN 108456183 A申请人: UNIV SHANGHAI ENG SCIENCE优先权: 2018
CN
PHARMACEUTICAL COMBINATION AND APPLICATION THEREOF
US 20240342176 A1申请人: GUANGZHOU JOYO PHARMATECH CO LTD优先权: 2021
US
药物组合及其应用
CN 115671289 B申请人: 广州嘉越医药科技有限公司优先权: 2021
CN
COMBINATION CANCER TREATMENTS WITH A COMPOSITION COMPRISING AN MTOR PATHWAY INHIBITOR
WO 2025049962 A1申请人: AADI BIOSCIENCE INC优先权: 2023
WO
TREATMENT OF OCULAR DISEASES USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL)PHENYL)-3-[4-(4,6- DIMORPHOLIN-4- YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA
WO 2025128712 A1申请人: CELCUITY INC优先权: 2023
WO
Preparation method of Gedatolisib key intermediate
CN 118745159 A申请人: ZHEJIANG UNIV QUZHOU RESEARCH INSTITUTE优先权: 2024
CN
Application of small molecule compound in preparation of product for inhibiting 3C-like cysteine protease
CN 120570893 A申请人: INST MILITARY MEDICINE ACADEMY MILITARY SCIENCES PLA优先权: 2025
CN

药物